Skip to content

BRAUN STACEY ASSOCIATES INC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BRAUN STACEY ASSOCIATES INC on CME, newest first. How the timeline and the estimate are built.

BRAUN STACEY ASSOCIATES INC held 117,163 CME shares at 2026-06-30 per its 13F-HR filed 2026-08-05.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 117,163 shares
    Change vs previous 13F +5,398 shares

    0.73% of the 13F portfolio, value $25,873,105.

    13F-HR 0001213900-26-085531 filed by BRAUN STACEY ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 111,765 shares
    Change vs previous 13F +7,560 shares

    1.1% of the 13F portfolio, value $33,009,793.

    13F-HR 0001213900-26-046430 filed by BRAUN STACEY ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 104,205 shares
    Change vs previous 13F +6,951 shares

    0.92% of the 13F portfolio, value $28,456,301.

    13F-HR 0001213900-26-005653 filed by BRAUN STACEY ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 97,254 shares
    Change vs previous 13F +7,336 shares

    0.86% of the 13F portfolio, value $26,277,058.

    13F-HR 0001213900-25-100586 filed by BRAUN STACEY ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 89,918 shares
    Change vs previous 13F not available

    0.9% of the 13F portfolio, value $24,783,199.

    13F-HR 0001213900-25-074748 filed by BRAUN STACEY ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).